Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Nivolumab + Docetaxel + ADT for Metastatic Prostate Cancer
Recruiting1 awardPhase 2
Tampa, Florida
This trial is studying a combination of ADT, chemotherapy, and immunotherapy to see if it is an effective treatment for hormone-sensitive prostate cancer that has spread to other parts of the body.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service